MAP2K7 and neuroblastoma: Previously, Eppstein and colleagues have investigated the effects of the MEK inhibitor U0126 against three NB cell lines representing the three types of cells; SK-N-AS (S-type), SH-SY5Y (N-type) and BE(2)-C (I-type) [21].